1 ATP and ATP analogues induced prostacyclin (PGI2) secretion from human cultured umbilical vein endothelial cells. 2 The threshold active concentration for ATP was <1 M. The rank order of potency of analogues was 2-chloroadenosine 5'-triphosphate (2-CIATP) > 2-methylthioadenosine 5'-triphospate (2-MeSATP) > ATP > ADP, while adenosine 5'-(a, f-methylene)triphosphonate, AMP and adenosine were inactive, indicating the presence of P2Y-purinoceptors.
Introduction
Vascular endothelial cells modulate the activity of adjacent smooth muscle cells and platelets in response to a variety of stimuli, through the release of the vasoactive mediators endothelium-derived relaxant factor (EDRF; Furchgott & Zawadski, 1980) and prostacyclin (PGI2; Moncada et al., 1977) . Extracellular adenosine 5'-triphosphate (ATP) has actions via P2-purinoceptors on a variety of tissues (Burnstock & Kennedy, 1985;  Gordon, 1986) , but in particular it is a potent inducer of EDRF release in vascular tissue (De Mey & Vanhoutte, 1981; Gordon & Martin, 1983) (Schwartzman & Raz, 1982; Pearson et al., 1983; Van Coevorden & Boeynaems, 1983; McIntyre et al., 1985) . However, the intracellular mechanisms that couple activation of P2-purinoceptors to [Ca2+]i above a threshold value of 0.8-1.0 uM is necessary for thrombin-stimulated PGI2 release (Hallam et al., 1988) . In this study we have used a series of ATP analogues to characterize the P2-purinoceptor on human umbilical vein endothelial cells that mediates PGI2 production. We then determined that PGI2 synthesis in response to activation of this receptor requires elevated [Ca2+] i and, in addition, that this rise in [Ca21]i provides the major, if not the exclusive, transduction signal for prostanoid synthesis.
Methods

Cell culture
Endothelial cells were isolated and cultured from segments of human umbilical vein as previously described (Jaffe et al., 1973; Hallam et al., 1988 
Determination of PGI2 release
Confluent monolayers of cells in 16 mm diameter wells (-10' cells per well) were used for the replicate determination of PGI2 release. The complete growth medium in each well was replaced with serum-free 20 mm HEPES-buffered Dulbecco's medium. After 30 min it was carefully removed and replaced with 1.2 ml of the same medium. Five minutes later 0.2 ml was removed and stored at 4°C. A further 0.2 ml aliquot was removed 25 min later followed immediately by the addition of 0.2 ml of medium containing a stimulatory agonist. A final sample was taken 5 min later. The stable hydrolysis product of PGI2, 6-keto-prostaglandin F1Q (6-keto-PGFg), was determined in each aliquot by specific radioimmunoassay (Ager et al., 1982) .
Basal PGI2 release rates were measured over the period 5-30 min, thus eliminating the transient release caused simply by removing and replacing the medium; and stimulated release rates were measured over the 30-35 min period.
In some experiments PGI2 release was determined concomitantly with [Ca2 ]i by subsampling the medium above coverslips of fura-2 loaded cells (see below).
Determination of [Ca2+]i
Confluent monolayers of cells on glass coverslips were loaded with fura-2 by incubating the cells with 1 /M fura-2 acetoxymethyl ester in Dulbecco's medium containing 20% (v/v) foetal calf serum for 45 min at 37°C (Hallam & Pearson, 1986) . The coverslips were then transferred to a HEPESbuffered physiological saline of the following composition (in mM): NaCl 145, KCl 5, MgSO4 1, HEPES, 10, CaCl2 1, glucose 10; pH 7.4 at 37°C.
Cells on coverslips were then allowed to cool to room temperature to minimize the loss of active dye through leakage from the cells, and used within 60min. For each experiment a coverslip was placed diagonally in a quartz cuvette containing buffer.
Fluorescence was recorded continuously (excitation wavelength 340 nm; emission 500 nm) in an AmincoBowman fluorescence spectrometer with a thermostatted cuvette holder at 37°C. Calibration of the fluorescent signal was as described by Hallam & Pearson (1986) .
Assessment ofenhanced permeability in response to ATP Confluent monolayers of cells in 16mm diameter wells were treated with various doses of ATP for 5 min using exactly the same experimental protocol as that for determination of stimulated PGI2 release.
Twenty five yl of 1 mm ethidium bromide were then added to each well for 5 min, after which the monolayers were rinsed in phosphate-buffered saline and examined by fluorescence microscopy using a Leitz Dialux microscope with an IT-2-auramine filter. Cells that are impermeable to the dye do not fluoresce, those rendered permeable have fluorescent nuclei (due to dye intercalated with DNA) and can be counted (Gomperts, 1983 (0) Figure 7b confirm that if the antagonist was added first, histamine was completely inactive. (Figure 9 ). Burnstock & Kennedy (1985) , which are linked to PGI2 synthesis and EDRF production Martin et al., 1985; Needham et al., 1987) . In addition, in porcine and bovine endothelial cells P2-receptor occupation is accompanied by transient elevations in
[Ca2+]i (Hallam & Pearson, 1986; Luckhoff & Busse, 1986 (Burnstock, 1978) . The response was transient regardless of whether the ATP analogues tested were susceptible or resistant (ATPyS; Cusack et al., 1983) to hydro- ( 1985) and Gordon (1986) , like the purinoceptor we 0.0 0 previously described on porcine endothelium°( urinary bladder was not related to electronegativity
[Ca2+], (VLM) . Thus 2-MeSAPPCF2P was Dose-response relationship between peak slightly more potent than ATP itself and 70 x more and prostacyclin (PGI2) release in human potent than 2-MeSAPPCP on taenia coli, and it was vein endothelial cells in response to ionomysuggested that this feature might be a characteristic LTP (O) or 2-chloroadenosine 5'-triphosphate of P2y-purinoceptors teristics as that on taenia coli with respect to its response to these analogues. In several cell types exogenous ATP nonselectively increases membrane permeability so that low MR components (including ATP) can be released (Gordon, 1986) . In the mast cell the pharmacological characterization of a P2-receptor, which recognises ATP4-and is linked to enhanced membrane permeability and histamine secretion (Cockcroft & Gomperts, 1980) , has recently been described (Tatham et al., 1988) . This receptor has some features that are reminiscent of the P2y-purinoceptor; e.g. it is recognised by 2-substituted analogues and not, except at very high doses, by APCPP, though it is clearly a distinct P2-purinoceptor type. Since we have previously noted purine release from perfused columns of porcine aortic endothelial cells cultured on microcarrier beads in response to 100pM ATP (Needham et al., 1987) , we were concerned to determine whether any enhanced permeability was detectable in our current experiments. The lack of any effect of ATP at doses of up to 500ym demonstrates, first, that the dose-response curves for PGI2 release obtained were not complicated by release of endogenous ATP. Second, it shows that endothelial P2Y-receptor occupation does not lead to enhanced membrane permeability of the type found in the mast cell, which has not been demonstrated previously.
P2Y-purinoceptor-mediated elevation of [Ca2+2i ATP and its active analogues induced dosedependent elevations of [Ca21] i. In the presence of extracellular Ca2 , the response consisted of two phases; an initial rapid and transient peak followed by a long-lasting plateau phase where the concentration achieved was also dose-related. We conclude that the first phase consists predominantly of discharge of Ca2 + from bound intracellular stores, because it was maintained in the absence of extracellular Ca2+ or when Ni2+ was added extracellularly in a concentration sufficient to block Ca2+ uptake (Hallam & Rink, 1985) . We conclude that the second phase is due to influx of Ca2+ across the plasma membrane, because it was not found in the absence of extracellular Ca2+ or when Ca2+ influx was blocked by Ni2+, and it could be reversibly inhibited by chelation of extracellular Ca2+ with EGTA.
Ca2+ influx was insensitive to pretreatment with a voltage-operated Ca2+ channel blocker (10pM nifedipine). The influx of Ca2+ in response to histamine was rapidly terminated by the addition of an H1-antagonist. We therefore presume that this Ca2+ influx in response either to histamine, ATP or thrombin (Hallam et al., 1988 ) is due to activation of a Ca2 + entry mechanism following agonist addition. [Ca2+]i rose to a steady-state elevated level when external Ca2+ was replaced a few minutes after ATP in these experiments. The simplest interpretation (although others cannot be excluded) for this rise is that Ca2+ entry was stimulated and maintained in the presence of ATP. The lack of a full [Ca2+]i transient response (with an initial peak of PGI2 production) under these conditions implies that the internal store of Ca2 + cannot refill sufficiently quickly and/or, more plausibly, that the transduction mechanisms leading to its release rapidly become refractory to ATP. This is consistent with the rapid induction of homologous desensitization of agonistmediated PGI2 release in these cells (Toothill et al., 1988 (Lambert et al., 1987; Pirotton et al., 1987) . Thus while diacylglycerol formation, and hence protein kinase C modulated transduction pathways, may contribute to other P2Y-mediated endothelial responses, they seem to be unimportant in initiating PGI2 synthesis.
Conclusions
Human umbilical vein endothelial cells possess P2y-purinoceptors linked to PGI2 synthesis. P2Y-mediated PGI2 release is due to transient elevation of [Ca2+]i derived predominantly from intracellular bound stores, as we have previously found for thrombin-induced PGI2 synthesis (Hallam et al., 1988) . P2Y agonists also stimulate Ca2 + influx.
Whilst this influx contributes little to PGI2 synthesis, it may well be relevant to the production of EDRF, which is longer-lasting and requires extracellular Ca2+ (Singer & Peach, 1984) , and further experiments are needed to test this hypothesis.
